McKesson Corporation Completes Sale of Rexall and Well.ca

IRVING, Texas — McKesson Corporation (NYSE: MCK) has announced the successful completion of the sale of its Canada-based Rexall and Well.ca businesses. This transaction was finalized on December 30, 2024, following the initial announcement made in September 2024.

The buyer, Birch Hill Equity Partners, is a private equity firm based in Canada. This move allows McKesson to redirect its focus and capital towards expanding its strategic interests, particularly in oncology and biopharma.

Impact on McKesson's Operations

By divesting these businesses, McKesson aims to enhance its capital deployment strategy and concentrate on core growth areas. The divestiture signifies McKesson's commitment to advancing its healthcare services and expanding its capabilities in critical sectors.

Future Outlook

Further details regarding the sale can be accessed through McKesson's Investor Relations website. The company continues to emphasize its dedication to improving health outcomes and making quality healthcare more accessible.

McKesson, Rexall, Business